Uncategorized-EN

iEuroEwing is a Phase III international clinical trial to optimize treatment for Ewing sarcoma patients. Agents: Systemic and local therapies Phase III Status Recruiting Sponsor Co-funding of national funding bodies   Further information can be found here.   WHO is the trial for? The trial is open for patients diagnosed with Ewing sarcoma or Ewing-like…

USA: Sarcoma Alliance  Back to members Organisation Profile The Sarcoma Alliance strives to improve the lives of people affected by sarcoma through accurate diagnosis, improved access to care, guidance, education and support. Suzanne Leider founded the Sarcoma Alliance in 1999 in the living room of her home with the mantra “guidance, education, and support” in…

  USA: Sarcoma Coalition  Back to members Organisation Profile The Sarcoma Coalition is comprised of Patient Advocacy organizations and foundations that represent a cross-section of sarcoma subtypes or a pan-sarcoma group. There is no individual membership. The membership of the Coalition has a designated representative to participate in the Roundtable meetings of the Sarcoma Coalition…

Uganda: Uganda Alliance of Patients’ Organizations (UAPO) Back to members Organisation’s profile  UAPO is a patient-driven not-for-profit civil society organization founded in 2011. UAPO leads the patients voice through membership,collaboration and partnerships with other patient and advocacy organizations; healthcare professionals, private sector entities,pharmaceutical industry; regulatory authorities, policy makers, NGOs, academics,researchers, consumer organizations; patient advocacy groups;…

A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma (Osteomyc) Agents: OMO-103 Phase II Status Open, recruiting Sponsor Vall d’Hebron Institute of Oncology This is an open-label, unicentric, single-arm Phase 2 pilot study to serve as a proof-of-concept…